Tech Company Financing Transactions
Xenon Pharmaceuticals Funding Round
On 12/8/2006, Xenon Pharmaceuticals raised $7 million in investment from Roche Venture Fund.
Transaction Overview
Company Name
Announced On
12/8/2006
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Xenon and Roche have entered into an exclusive worldwide research and license agreement to jointly research protein-based inhibitors of HJV. In addition to the research and license agreement, the Roche Venture Fund has purchased $7 Million of Xenon stock.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3650 Gilmore Way
Burnaby BC, V5G 4W8
Canada
Burnaby BC, V5G 4W8
Canada
Phone
Website
Email Address
Overview
Xenon Pharmaceuticals (NASDAQ: XENE) is a leader in clinical genetic based drug discovery and development and have built a worldwide network of over 40 clinical collaborators to find and access the rare families with diseases of relevance to drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Simon Pimstone
Chief Financial Officer
Ian Mortimer
Chief Medical Officer
Ernesto Aycardi
Vice President
Charles Cohen
Vice President
James Empfield
VP - Bus. Development
Robin Sherrington
VP - Regulatory Affairs
Jodi Regts
Browse more venture capital transactions:
Prev: 12/8/2006: Crescendo Networks venture capital transaction
Next: 12/11/2006: Untangle venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs